“Professional Ethics and Responsibilities for Business Valuation, Business Ownership Interest, Security, or Intangible Assets in Pharmaceutical Companies”, Journal of Pharmaceutical Negative Results, pp. 1572–1576, Nov. 2022, doi: 10.47750/pnr.2022.13.S09.193.